Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

Francesco Caponigro; Gerardo Rosati; Patrizia De Rosa; Antonio Avallone; Vincenzo De Rosa; Luigi De Lucia; Pasquale Comella; Giuseppe Comella

doi:10.1159/000065470

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

Oncology ◽

10.1159/000065470 ◽

2002 ◽

Vol 63 (3) ◽

pp. 232-238 ◽

Cited By ~ 13

Author(s):

Francesco Caponigro ◽

Gerardo Rosati ◽

Patrizia De Rosa ◽

Antonio Avallone ◽

Vincenzo De Rosa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Randomized Study ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A phase II study of vinorelbine (VRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81098-3 ◽

1999 ◽

Vol 35 ◽

pp. S176

Author(s):

V. Guillem ◽

M.A. Muñoz ◽

R. Yaya ◽

V. Soriano ◽

M.A. Climent ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

Seminars in Oncology ◽

10.1053/j.seminoncol.2003.11.011 ◽

2003 ◽

Vol 30 ◽

pp. 84-88 ◽

Cited By ~ 17

Author(s):

Robert Haddad ◽

Lori Wirth ◽

Rosemary Costello ◽

Linda Weeks ◽

Marshall Posner

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Randomized Study ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Newly Diagnosed ◽

Concomitant Chemoradiation

Download Full-text

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

Cancer ◽

10.1002/(sici)1097-0142(19990215)85:4<952::aid-cncr25>3.0.co;2-n ◽

1999 ◽

Vol 85 (4) ◽

pp. 952-959 ◽

Cited By ~ 6

Author(s):

Francesco Caponigro ◽

Pasquale Comella ◽

Paolo Marcolin ◽

Francesco Russo Spena ◽

Maria Biglietto ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

International Journal of Oral and Maxillofacial Surgery ◽

10.1016/s0901-5027(00)80102-2 ◽

2000 ◽

Vol 29 (3) ◽

pp. 232

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

International Journal of Oral and Maxillofacial Surgery ◽

10.1034/j.1399-0020.2000.290317-2.x ◽

2000 ◽

Vol 29 (3) ◽

pp. 232-234

Author(s):

F. Caponigro ◽

P. Comella ◽

P. Marcolin ◽

F. R. Spena ◽

M. Biglietto ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)

Annals of Oncology ◽

10.1023/a:1008322415335 ◽

2001 ◽

Vol 12 (2) ◽

pp. 199-202 ◽

Cited By ~ 24

Author(s):

F. Caponigro ◽

E. Massa ◽

L. Manzione ◽

G. Rosati ◽

M. Biglietto ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Southern Italy ◽

Phase Ii Study ◽

Locally Advanced ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3359960.3049058 ◽

2010 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Prospective Trial ◽

Advanced Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text